Taken together, these results show the feasibility of correcting the phenotype of FA cells using gene targeting strategies, in particular by promoting the insertion and expression of FANCA in the AAVS1 safe harbor locus of fibroblasts from FA-A patients. The gene discussed is FANCA; the disease is Fanconi anemia complementation group A.